Skip to main content
Erschienen in: World Journal of Urology 5/2013

01.10.2013 | Topic Paper

Epidemiological gender-specific aspects in urolithiasis

verfasst von: Christian Seitz, Harun Fajkovic

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The incidence of urolithiasis is worldwide increasing and contributes to a rising economic and health care burden. The objective of this review is to identify gender differences in urolithiasis epidemiology in Europe and the USA as well as gender-specific risk factors for urolithiasis.

Evidence acquisition

A systematic review of the present literature was performed including English journals without a time limit. The MeSH terms used were as follows: (“Sex Characteristics”[Mesh]) AND “Urolithiasis”[Mesh] or (“Epidemiology”[Mesh]) AND “Urolithiasis”[Mesh]. Additionally, reference search of retrieved papers identified additional references. The MEDLINE database was searched.

Evidence synthesis

The prevalence of urolithiasis is rising worldwide including both genders in different age groups. Especially women face an increase in prevalence in the USA. Overweight seems to be an important cause for this development. Additionally insulin resistance and hypertonia, conditions present in the metabolic syndrome complex, contribute to this phenomenon.

Conclusion

Stone prevalence across all age groups and both genders is increasing. Lifestyle changes along with increasing prevalence of obesity are key factors for this development. Female gender did significantly differ in the risk ratio of stone development in different variables including body mass index, hyperinsulinemia, and hypertension. It is important to inform the public on measures how to change lifestyle and dietary measures for preventing or lowering events of stone disease.
Literatur
1.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68(3):1230–1235PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68(3):1230–1235PubMedCrossRef
2.
Zurück zum Zitat Shekarriz B, Stoller ML (2002) Uric acid nephrolithiasis: current concepts and controversies. J Urol 168(4 Pt 1):1307–1314PubMed Shekarriz B, Stoller ML (2002) Uric acid nephrolithiasis: current concepts and controversies. J Urol 168(4 Pt 1):1307–1314PubMed
3.
Zurück zum Zitat Hesse A et al (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713PubMedCrossRef Hesse A et al (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713PubMedCrossRef
4.
5.
Zurück zum Zitat Trinchieri A et al (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 37(1):23–25PubMedCrossRef Trinchieri A et al (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 37(1):23–25PubMedCrossRef
6.
Zurück zum Zitat Stamatelou KK et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef Stamatelou KK et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef
7.
Zurück zum Zitat Lieske JC et al (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764PubMedCrossRef Lieske JC et al (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764PubMedCrossRef
8.
Zurück zum Zitat Strope SA, Wolf Jr JS, Hollenbeck BK (2010) Changes in gender distribution of urinary stone disease. Urology 75(3):543–546.e1 Strope SA, Wolf Jr JS, Hollenbeck BK (2010) Changes in gender distribution of urinary stone disease. Urology 75(3):543–546.e1
9.
Zurück zum Zitat Daudon M et al (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32(3):241–247PubMedCrossRef Daudon M et al (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32(3):241–247PubMedCrossRef
10.
Zurück zum Zitat Knoll T et al (2011) Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 185(4):1304–1311PubMedCrossRef Knoll T et al (2011) Urolithiasis through the ages: data on more than 200,000 urinary stone analyses. J Urol 185(4):1304–1311PubMedCrossRef
11.
Zurück zum Zitat Soucie JM et al (1994) Demographic and geographic variability of kidney stones in the United States. Kidney Int 46(3):893–899PubMedCrossRef Soucie JM et al (1994) Demographic and geographic variability of kidney stones in the United States. Kidney Int 46(3):893–899PubMedCrossRef
12.
Zurück zum Zitat Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857PubMedCrossRef Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857PubMedCrossRef
13.
Zurück zum Zitat Hiatt RA et al (1982) Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol 115(2):255–265PubMed Hiatt RA et al (1982) Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol 115(2):255–265PubMed
14.
Zurück zum Zitat Scales CD Jr et al (2007) Changing gender prevalence of stone disease. J Urol 177(3):979–982PubMedCrossRef Scales CD Jr et al (2007) Changing gender prevalence of stone disease. J Urol 177(3):979–982PubMedCrossRef
15.
Zurück zum Zitat Scales CD (ed) (2013) Epidemiology of stone disease. In: Knoll T, Pearle M (eds) Clinical management of urolithiasis. Springer, Heidelberg, pp 1–8 Scales CD (ed) (2013) Epidemiology of stone disease. In: Knoll T, Pearle M (eds) Clinical management of urolithiasis. Springer, Heidelberg, pp 1–8
16.
Zurück zum Zitat Perucca J et al (2007) Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol 292(2):R700–R705PubMedCrossRef Perucca J et al (2007) Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol 292(2):R700–R705PubMedCrossRef
17.
Zurück zum Zitat Hadj-Aissa A et al (1992) Influence of the level of hydration on the renal response to a protein meal. Kidney Int 42(5):1207–1216PubMedCrossRef Hadj-Aissa A et al (1992) Influence of the level of hydration on the renal response to a protein meal. Kidney Int 42(5):1207–1216PubMedCrossRef
18.
Zurück zum Zitat Ebner A, Manz F (2002) Sex difference of urinary osmolality in German children. Am J Nephrol 22(4):352–355PubMedCrossRef Ebner A, Manz F (2002) Sex difference of urinary osmolality in German children. Am J Nephrol 22(4):352–355PubMedCrossRef
19.
Zurück zum Zitat Hercberg S et al (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164(21):2335–2342PubMedCrossRef Hercberg S et al (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164(21):2335–2342PubMedCrossRef
20.
Zurück zum Zitat Sacks FM et al (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344(1):3–10PubMedCrossRef Sacks FM et al (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344(1):3–10PubMedCrossRef
21.
Zurück zum Zitat Sarada B, Satyanarayana U (1991) Urinary composition in men and women and the risk of urolithiasis. Clin Biochem 24(6):487–490PubMedCrossRef Sarada B, Satyanarayana U (1991) Urinary composition in men and women and the risk of urolithiasis. Clin Biochem 24(6):487–490PubMedCrossRef
22.
Zurück zum Zitat Parks JH, Barsky R, Coe FL (2003) Gender differences in seasonal variation of urine stone risk factors. J Urol 170(2 Pt 1):384–388PubMedCrossRef Parks JH, Barsky R, Coe FL (2003) Gender differences in seasonal variation of urine stone risk factors. J Urol 170(2 Pt 1):384–388PubMedCrossRef
23.
Zurück zum Zitat Wang YX et al (1995) Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats. Am J Physiol 268(4 Pt 2):R951–R957PubMed Wang YX et al (1995) Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats. Am J Physiol 268(4 Pt 2):R951–R957PubMed
24.
Zurück zum Zitat Wang YX et al (1996) Sex difference in urinary concentrating ability of rats with water deprivation. Am J Physiol 270(3 Pt 2):R550–R555PubMed Wang YX et al (1996) Sex difference in urinary concentrating ability of rats with water deprivation. Am J Physiol 270(3 Pt 2):R550–R555PubMed
25.
Zurück zum Zitat Novak TE et al (2009) Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology 74(1):104–107PubMedCrossRef Novak TE et al (2009) Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology 74(1):104–107PubMedCrossRef
26.
Zurück zum Zitat Trinchieri A et al (1996) Clinical observations on 2086 patients with upper urinary tract stone. Arch Ital Urol Androl 68(4):251–262PubMed Trinchieri A et al (1996) Clinical observations on 2086 patients with upper urinary tract stone. Arch Ital Urol Androl 68(4):251–262PubMed
27.
Zurück zum Zitat Marickar YM, Vijay A (2009) Female stone disease: the changing trend. Urol Res 37(6):337–340PubMedCrossRef Marickar YM, Vijay A (2009) Female stone disease: the changing trend. Urol Res 37(6):337–340PubMedCrossRef
28.
Zurück zum Zitat Preminger GM et al (2005) Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000PubMedCrossRef Preminger GM et al (2005) Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173(6):1991–2000PubMedCrossRef
29.
Zurück zum Zitat Andreassen KPA, Olsen PR, Aabeck J, Osther PJ (2007) Classification of urolithiasis in Denmark: a national survey. Eur Urol Meet 2(1):126 Andreassen KPA, Olsen PR, Aabeck J, Osther PJ (2007) Classification of urolithiasis in Denmark: a national survey. Eur Urol Meet 2(1):126
30.
Zurück zum Zitat Siener R et al (2003) Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol 44(4):467–474PubMedCrossRef Siener R et al (2003) Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol 44(4):467–474PubMedCrossRef
31.
Zurück zum Zitat Ahlstrand C, Tiselius HG (1990) Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 18(6):397–399PubMedCrossRef Ahlstrand C, Tiselius HG (1990) Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 18(6):397–399PubMedCrossRef
32.
Zurück zum Zitat Sarica K et al (2009) Role of overweight status on stone-forming risk factors in children: a prospective study. Urology 73(5):1003–1007PubMedCrossRef Sarica K et al (2009) Role of overweight status on stone-forming risk factors in children: a prospective study. Urology 73(5):1003–1007PubMedCrossRef
33.
Zurück zum Zitat Negri AL et al (2008) Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36(6):303–307PubMedCrossRef Negri AL et al (2008) Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36(6):303–307PubMedCrossRef
34.
Zurück zum Zitat Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48(6):905–915PubMedCrossRef Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48(6):905–915PubMedCrossRef
35.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293(4):455–462PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293(4):455–462PubMedCrossRef
36.
Zurück zum Zitat Nowfar S et al (2011) The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urology 78(5):1029–1033PubMedCrossRef Nowfar S et al (2011) The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urology 78(5):1029–1033PubMedCrossRef
37.
Zurück zum Zitat Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46(2):263–269PubMedCrossRef Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46(2):263–269PubMedCrossRef
38.
Zurück zum Zitat Semins MJ et al (2010) The association of increasing body mass index and kidney stone disease. J Urol 183(2):571–575PubMedCrossRef Semins MJ et al (2010) The association of increasing body mass index and kidney stone disease. J Urol 183(2):571–575PubMedCrossRef
39.
Zurück zum Zitat Duffey BG et al (2008) Lithogenic risk factors in the morbidly obese population. J Urol 179(4):1401–1406PubMedCrossRef Duffey BG et al (2008) Lithogenic risk factors in the morbidly obese population. J Urol 179(4):1401–1406PubMedCrossRef
40.
Zurück zum Zitat Powell CR et al (2000) Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55(6):825–830PubMedCrossRef Powell CR et al (2000) Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55(6):825–830PubMedCrossRef
41.
Zurück zum Zitat Daudon M, Lacour B, Jungers P (2005) High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 20(2):468–469PubMedCrossRef Daudon M, Lacour B, Jungers P (2005) High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 20(2):468–469PubMedCrossRef
42.
Zurück zum Zitat Curhan GC et al (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328(12):833–838PubMedCrossRef Curhan GC et al (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328(12):833–838PubMedCrossRef
43.
Zurück zum Zitat Curhan GC et al (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126(7):497–504PubMedCrossRef Curhan GC et al (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126(7):497–504PubMedCrossRef
44.
Zurück zum Zitat Curhan GC et al (2004) Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med 164(8):885–891PubMedCrossRef Curhan GC et al (2004) Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med 164(8):885–891PubMedCrossRef
45.
Zurück zum Zitat Borghi L et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84PubMedCrossRef Borghi L et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84PubMedCrossRef
Metadaten
Titel
Epidemiological gender-specific aspects in urolithiasis
verfasst von
Christian Seitz
Harun Fajkovic
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1140-1

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.